Accredited Investors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $295K | Hold |
|
|||||
|
2025
Q2 | $382K | Hold |
|
|||||
|
2025
Q1 | $299K | Hold |
|
|||||
|
2024
Q4 | $340K | Sell |
|
|||||
|
2024
Q3 | $302K | Hold |
|
|||||
|
2024
Q2 | $511K | Sell |
|
|||||
|
2024
Q1 | $644K | Buy |
|
|||||
|
2023
Q4 | $560K | Hold |
|
|||||
|
2023
Q3 | $421K | Hold |
|
|||||
|
2023
Q2 | $580K | Sell |
|
|||||
|
2023
Q1 | $570K | Hold |
|
|||||
|
2022
Q4 | $555K | Buy |
|
|||||
|
2022
Q3 | $395K | Sell |
|
|||||
|
2022
Q2 | $373K | Sell |
|
|||||
|
2022
Q1 | $641K | Buy |
|
|||||
|
2021
Q4 | $670K | Hold |
|
|||||
|
2021
Q3 | $682K | Sell |
|
|||||
|
2021
Q2 | $544K | Sell |
|
|||||
|
2021
Q1 | $479K | Sell |
|
|||||
|
2020
Q4 | $586K | Hold |
|
|||||
|
2020
Q3 | $653K | Sell |
|
|||||
|
2020
Q2 | $671K | Sell |
|
|||||
|
2020
Q1 | $477K | Sell |
|
|||||
|
2019
Q4 | $476K | Hold |
|
|||||
|
2019
Q3 | $325K | Hold |
|
|||||
|
2019
Q2 | $326K | Sell |
|
|||||
|
2019
Q1 | $274K | Buy |
|
|||||
|
2018
Q4 | $253K | Sell |
|
|||||
|
2018
Q3 | $339K | Hold |
|
|||||
|
2018
Q2 | $225K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $201K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $207K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $204K | Buy |
|